Literature DB >> 618380

Diffuse coronary artery disease in diabetic patients: fact or fiction?

A C Dortimer, P N Shenoy, R A Shiroff, D M Leaman, J D Babb, A J Liedtke, R Zelis.   

Abstract

To compare angiographically-determined coronary artery disease in diabetic patients with controls, 1,653 patients coming to cardiac catheterization were reviewed retrospectively to find 37 diabetic and 79 control patients matched for sex, age (+/- 3 years), and risk factors (hypertension, hyperlipidemia, and smoking). The severity of coronary artery disease was assessed using an angiographic grading system. The following results were obtained: 16 of 37 diabetic patients (43%) had three-vessel disease compared to 20 of 79 controls (25%). Seventy-six of 111 (68%) diabetic vessels were diseased compared to 110 of 237 control vessels (46%) (P less than 0.005). The total coronary score reflecting total extent of disease for diabetic patients was 371 (mean 10.0 +/- (SEM) compared to 594 for controls (mean 7.5 +/- 0.7, (P less than 0.01). Diabetic patients had a statistically similar number of diffusely diseased vessels as controls (28% vs 22%). There were only three of 76 diabetic vessels (4%) considered inoperable compared to seven of 110 (6%) control vessels. We conclude that diabetic patients with chest pain have more coronary artery disease than nondiabetics, but no more diffuse or inoperable disease.

Entities:  

Mesh:

Year:  1978        PMID: 618380     DOI: 10.1161/01.cir.57.1.133

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Are complex coronary lesions more frequent in patients with diabetes mellitus?

Authors:  Nezihi Baris; Bahri Akdeniz; Samet Uyar; Erdem Ozel; Onder Kirimli; Ozer Badak; Ozgur Aslan; Sema Guneri
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

Review 3.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

4.  The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus.

Authors:  A Dawson; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

Review 5.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

6.  Non invasive evaluation of left ventricular performance in 294 diabetic patients without clinical heart disease.

Authors:  L dei Cas; U Zuliani; C Manca; A Zonca; B Bernardini; M Mansour; A L Barilli
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

7.  Severity of coronary artery disease in type 2 diabetes mellitus: Does the timing matter?

Authors:  Mukund P Srinivasan; Padmanabh K Kamath; Narayan M Bhat; Narasimha D Pai; Rajesh U Bhat; Tejas D Shah; Anish Singhal; Chakrapani Mahabala
Journal:  Indian Heart J       Date:  2016-01-19

8.  Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era.

Authors:  Maria Theresa H Santos; Matthew W Parker; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-08-21       Impact factor: 5.952

Review 9.  Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.

Authors:  K P Morgan; A Kapur; K J Beatt
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 10.  The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.

Authors:  Chris P H Lexis; Braim M Rahel; Joan G Meeder; Felix Zijlstra; Iwan C C van der Horst
Journal:  Cardiovasc Diabetol       Date:  2009-07-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.